246 related articles for article (PubMed ID: 19958824)
1. Bioadhesion and oral absorption of enoxaparin nanocomplexes.
Sun W; Mao S; Wang Y; Junyaprasert VB; Zhang T; Na L; Wang J
Int J Pharm; 2010 Feb; 386(1-2):275-81. PubMed ID: 19958824
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and enoxaparin.
Sun W; Mao S; Mei D; Kissel T
Eur J Pharm Biopharm; 2008 Jun; 69(2):417-25. PubMed ID: 18294825
[TBL] [Abstract][Full Text] [Related]
3. Exploration of hydrophobic modification degree of chitosan-based nanocomplexes on the oral delivery of enoxaparin.
Wang L; Li L; Sun Y; Tian Y; Li Y; Li C; Junyaprasert VB; Mao S
Eur J Pharm Sci; 2013 Nov; 50(3-4):263-71. PubMed ID: 23896170
[TBL] [Abstract][Full Text] [Related]
4. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
5. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
[TBL] [Abstract][Full Text] [Related]
6. Uptake, transport and peroral absorption of fatty glyceride grafted chitosan copolymer-enoxaparin nanocomplexes: influence of glyceride chain length.
Wang L; Sun Y; Shi C; Li L; Guan J; Zhang X; Ni R; Duan X; Li Y; Mao S
Acta Biomater; 2014 Aug; 10(8):3675-85. PubMed ID: 24814881
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of chitosan graft glyceryl monooleate as peroral delivery carrier of enoxaparin.
Wang L; Li L; Sun Y; Ding J; Li J; Duan X; Li Y; Junyaprasert VB; Mao S
Int J Pharm; 2014 Aug; 471(1-2):391-9. PubMed ID: 24882036
[TBL] [Abstract][Full Text] [Related]
8. Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles.
Jintapattanakit A; Junyaprasert VB; Mao S; Sitterberg J; Bakowsky U; Kissel T
Int J Pharm; 2007 Sep; 342(1-2):240-9. PubMed ID: 17597316
[TBL] [Abstract][Full Text] [Related]
9. Chitosan based polymer-lipid hybrid nanoparticles for oral delivery of enoxaparin.
Dong W; Wang X; Liu C; Zhang X; Zhang X; Chen X; Kou Y; Mao S
Int J Pharm; 2018 Aug; 547(1-2):499-505. PubMed ID: 29859924
[TBL] [Abstract][Full Text] [Related]
10. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Makhlof A; Tozuka Y; Takeuchi H
Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
[TBL] [Abstract][Full Text] [Related]
13. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
Fan B; Xing Y; Zheng Y; Sun C; Liang G
Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
[TBL] [Abstract][Full Text] [Related]
14. Delivery of protein drugs using nanoparticles self-assembled from dextran sulfate and quaternized chitosan.
Shu S; Zhang X; Wu Z; Wang Z; Li C
J Control Release; 2011 Nov; 152 Suppl 1():e170-2. PubMed ID: 22195830
[No Abstract] [Full Text] [Related]
15. A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability.
Quan P; Shi K; Piao H; Piao H; Liang N; Xia D; Cui F
Int J Pharm; 2012 Jul; 430(1-2):366-71. PubMed ID: 22531846
[TBL] [Abstract][Full Text] [Related]
16. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
17. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
18. Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in-vitro and in-vivo characterization.
Jain S; Sharma RK; Vyas SP
J Pharm Pharmacol; 2006 Mar; 58(3):303-10. PubMed ID: 16536896
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
[TBL] [Abstract][Full Text] [Related]
20. Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats.
Mei D; Mao S; Sun W; Wang Y; Kissel T
Eur J Pharm Biopharm; 2008 Nov; 70(3):874-81. PubMed ID: 18656537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
